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Kainate-type glutamate receptors (KARs) regulate synaptic transmission and neuronal excitability via
multiple mechanisms, depending on their subunit composition. Presynaptic KARs tonically depress
glutamatergic transmission during restricted period of synapse development; however, the molecular basis
behind this effect is unknown. Here, we show that the developmental and cell-type specific expression
pattern of a KAR subunit splice variant, GluK1c, corresponds to the immature-type KAR activity in the
hippocampus. GluK1c localizes to dendritic contact sites at distal axons, the distal targeting being promoted
by heteromerization with the subunit GluK4. Presynaptic expression of GluK1c strongly suppresses
glutamatergic transmission in cell-pairs in vitro and mimics the immature-type KAR activity at CA3-CA1
synapses in vivo, at a developmental stage when the endogenous expression is already downregulated. These
data support a central role for GluK1c inmediating tonic inhibition of glutamate release and the consequent
effects on excitability and activity-dependent fine-tuning of the developing hippocampal circuitry.
K
ainate-type of glutamate receptors (KARs) consist of homo- or heteromeric combinations of five subunits
(GluK1-5; previously known as GluR5-7, KA1 and KA2;1) and act as key modulators of neuronal function
in several areas of the brain. The precise role of KARs is strictly dependent on their subcellular localization
and subunit composition that varies between cell types and during development. At the presynaptic compart-
ment, KARs regulate transmitter release at both glutamatergic and GABAergic synapses and control presynaptic
forms of short-and long-term synaptic plasticity2–4. In the neonate CA1, presynaptic KARs are tonically activated
by ambient glutamate, causing continuous physiological suppression of glutamate release5. In addition to the
physiological relevance in controlling information transfer at the developing hippocampal circuitry, tonic KAR
activity is critical for formation and maturation of CA3-CA1 glutamatergic synapses6. The immature-type KARs
are gradually lost during second postnatal week in parallel with the activity-dependentmaturation of the neuronal
circuitry, and are replaced with adult – type KARs lacking tonic activity and with distinct downstream signaling
mechanisms5,7,8.
Many of the functions ascribed for KARs at developing glutamatergic synapses are sensitive to GluK1-subunit
specific agonists and antagonists5–9. The molecular composition of these receptors could be diverse since
these pharmacological tools act on both homomeric and heteromeric receptors containing the GluK1 subunit10.
In addition, GluK1 subunits exist as three C-terminal splice variants (named GluK1a, GluK1b and GluK1c), which
differ in their tissue-specific expression pattern, membrane delivery and protein interactions11,12. Heteromerization
of GluK1 with the subunits GluK4-5 provides KARs with higher agonist affinity13–15, necessary for activation by
physiological concentrations of glutamate in the immature brain5. However, the cell-type specific expression profile
or the developmental regulation of various GluK1 splice variants, as homomeric receptors or as heteromeric
combinations with other KAR subunits is not known.
Here we show that in the developing hippocampus, the splice variants GluK1b and GluK1c are preferentially
expressed in interneurons and pyramidal cells, respectively. GluK1c strongly co-localizes with the high-affinity
subunit GluK4, which promotes its targeting to distal neuronal processes. We further demonstrate that express-
ion of GluK1c at CA3 pyramidal neurons is sufficient to mimic the immature-type KAR activity at a devel-
opmental stage when the endogenous expression is already lost. These findings strongly suggest that the tonic
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KAR activity inhibiting glutamate release in the neonate is due to
developmentally restricted expression of GluK1c splice variant in the
principal neurons.
Results
GluK1mRNA is expressed in the principal neurons in the neonate
hippocampus. In situ hybridization studies have demonstrated that
GluK1 mRNA is prominently expressed in GABAergic interneurons
at juveline/adult hippocampus16–18. However, functional data as well
as some of the studies on GluK1 mRNA expression suggest that
GluK1 is present also on hippocampal principal neurons during
early postnatal development5,9,19,20. To determine the detailed
expression pattern of GluK1 in different cell types (pyramidal vs.
interneurons) during postnatal development, we performed double
in situ hybridization experiments at P3 and P15 hippocampus. Probe
against CaMKII-b isoform, highly expressed already early in
development21,22, was used as a marker for principal neurons. All
S35-labeled probes were first tested to ensure specific staining with
anti-sense probe and to control that there was no unspecific signal
with the corresponding sense mRNA (Supplementary Figure 1a,b).
At P3, GluK1 transcript was detected in CaMKII-b positive neu-
rons (referred to as principal/pyramidal neurons or dentate granule
cells from here on) everywhere in the hippocampus (Figure 1a,b).
The expression of GluK1 declined strongly during development and
at P15, co-expression of CaMKII-b and GluK1 was only observed in
the dentate gyrus (Figure 1a,b). The distribution of GluK1 transcript
between principal neurons and other cells in different regions of the
hippocampus was estimated by calculating the percentage of double
Figure 1 | Developmental regulation of GluK1 mRNA expression in the principal neurons of the hippocampus. (a) Images from in situ hybridization
with anti-sense GluK1 (S35-labeled, dark field image) and CaMKII-b (dig labeled, bright field image) probes in P3 and P15 hippocampus. Scale bar 200
mm. (b) Higher magnification figures of the double in situ hybridization staining in the pyramidal layer of CA1, CA3 and in the granule cells of dentate
gyrus (DG). GluK1 staining is observed as black granules, superimposed on the blue CaMKII-b staining at the bright field image. GluK1 expression is
detected in both CaMKII-b positive (principal) neurons and CaMKII-b negative (inter-) neurons in all areas of the neonate hippocampus (black and
white arrows, respectively), and in the granule cells at P15. Scale 50 mm. (c) Quantified data showing the distribution of GluK1 in principal neurons vs
other cells in different areas of hippocampus. The values represent the percentage principal neurons (i.e. GluK1 1 CaMKII-b positive cells) of all GluK1-
expressing cells that were calculated in rectangular fields positioned as depicted on the left. The percentages were obtained by analysis of at least four
independent sections, with a total of 40–64 cells in each group. All the error bars depict s.e.m. * p,0.05 with ANOVA on the raw data.
www.nature.com/scientificreports
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(i.e. CaMKII-b and GluK1) positive neurons of all GluK1 positive
cells. The analysis was done within fixed size (0.1125 mm2) rectangu-
lar regions as illustrated in the Figure 1c. At P3, 30–40 % of the cells
expressing GluK1 were principal neurons in all areas studied (a total
of 40–51 cells from 6–7 sections analyzed for each group, Figure 1c).
This percentage was significantly reduced during the first two weeks
of development in CA1 and in CA3 (11 % and 20 % at P15, respect-
ively), but not in the dentate gyrus (n546–64, Figure 1c). Thus, in the
neonate hippocampus, GluK1 mRNA is expressed in both principal
neurons and interneurons. During development, the expression in
the pyramidal neurons is lost, resulting predominant expression of
GluK1 in interneurons as well as dentate granule cells.
GluK1 is co-expressed with the high-affinity subunits GluK4 and
GluK5 during early development. Functional studies suggest that
the developmental switch in GluK1 containing KAR function is
associated with the change in the affinity of receptors5. A possible
mechanism for that is a change in heteromeric subunit composition
of the receptors, in particular with high-affinity subunits GluK4 and/
orGluK5. To examine possible alterations in the expression of GluK1
with GluK4 and GluK5 during development, we next analyzed the
co-expression of these subunits by double in situ hybridization.
At P3, GluK4 was detected in principal cells layers of the areas
CA1, CA3 and dentate gyrus (Figure 2a). Approximately 60% of the
cells expressing GluK1 were also positive for GluK4 in these areas
(n549–65; Figure 2b,c). In the juvenile (P15), GluK4 was not
detected in CA1 area, but was mainly expressed in CA3 pyramidal
cells layer and in some granule cells, as reported previously18,23. The
co-expression of GluK1 and GluK4 decreased significantly during
development, and at P15 few cells expressing GluK1 and GluK4 were
detected in area CA3, while some co-expression (26%) remained in
the dentate gyrus (n538–64; Figure 2c).
GluK5 was expressed in all pyramidal cell layers at P3 (Figure 2a).
As seen with GluK4, GluK1 was co-expressed with GluK5 at P3 in all
areas studied, though in a lesser degree: co-expression was detected
in 30–40% of GluK1 positive cells (n536–40; Figure 2b,d). Similarly,
the co-expression of GluK1 and GluK5 decreased considerable dur-
ing the second postnatal week in areas CA1 andCA3while no change
was seen in the dentate gyrus (n541–47; Figure 2d). Together, this
data indicates that in the neonate, GluK1 is expressed in the same
cells as the high-affinity subunits GluK4 and GluK5, and co-express-
ion is strongly reduced during development. This ismainly due to the
loss of GluK1 expression in pyramidal neurons.
GluK1c is the predominant splice variant expressed in the
pyramidal neurons. To study the expression profile of GluK1
splice variants in the neonate hippocampus, we first performed
RT-PCR experiments from two time points (P3 and P15). In line
Figure 2 | GluK1 is co-expressedwith the high-affinity subunits GluK4 andGluK5 in the neonate hippocampus. (a) In situ hybridization for GluK4 and
GluK5 mRNA in P3 hippocampal sections. Both subunits are widely expressed in principal neurons of the hippocampus during early postnatal
development. (b) Double in situ hybridization for GluK1 (S35) and GluK4/GluK5 (dig) in areas CA1, CA3 and in the dentate gyrus (DG) at P3. At P3,
GluK1 and GluK4 are strongly co-localized in all regions of the hippocampus (black arrows), while co-expression of GluK1 and GluK5 is strongest in the
area CA3. White arrows: GluK1 positive but GluK4/5 negative neurons. Scale 50 mm. (c,d) Quantification of the GluK1-GluK4/5 co-expression at
different hippocampal subfields at P3 vs P15. The values represent the percentage of GluK1 and GluK4/GluK5 double positive cells of all GluK1 positive
cells. 38–65 neurons from at least four sections were analyzed for each group. All the error bars depict s.e.m. * p,0.05, ** p,0.01, ***p,0.005 with
ANOVA on the raw data.
www.nature.com/scientificreports
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with the previous results11, GluK1a was not detected in the
hippocampus neither at P3 or P15, while GluK1b and -c were
expressed at both developmental stages (Figure 3a). This allowed
us to focus on GluK1b and -c variants in the following experiments.
The developmental decrease in GluK1 expression in pyramidal
neurons may be a consequence of the down-regulation of either
GluK1b or GluK1c mRNA or both. To distinguish between these
possibilities, we designed an oligodeoxyribonucleotide probe against
the c-terminal sequence encoding for the 29 amino acid insert pre-
sent in the c-splice variant but not in GluK1a or -b. In parallel, a
probe of approximately same length against the insert flanking
regions was used (Supplementary Figure 1c). The specificity of these
probes against GluK1 b and –c splice variants was first tested using
dot – blot assay. The probe against the GluK1c sequence showed no
cross – reactivity withGluK1b, while the other probe recognized both
the GluK1b- and c splice variants (Supplementary Figure 1d).
In situ hybridization with the radioactively labeled GluK1c and
GluK1b/c probes produced a patterned signal in the neonate (P3)
hippocampus (Figure 3b), while the corresponding sense-probes had
no reactivity (Supplementary Figure 1e). Further, the staining pat-
tern of the GluK1b/c probe was very similar to that obtained with the
long (503 bp) GluK1 – specific probe (Figure 1), further suggesting
that the short probes (99 and 87 bp) worked in a specific manner
under our hybridization conditions. In parallel in situ hybridizations
from P15 rat brain sections, the expression level of both GluK1b/c
and GluK1c transcripts in the hippocampus was considerably lower
than at P3. Quantification of the x-ray films exposed to sections
hybridized with the different radioactive probes indicated that the
expression of splice variant GluK1c decreased significantly more
during development as compared to the signal obtained with
GluK1b/c probe (Figure 3d; n54 sections for each group; p,0.04).
To examine whether the splice variants differ in their expression
pattern, we performed double in situ hybridization with CaMKII-b.
Interestingly, while the signal obtained with the GluK1b/c probe was
predominantly localized in the non-pyramidal neurons as expected,
the splice variant GluK1c was preferentially detected at pyramidal
neurons at P3, particularly in the area CA3 (n566–127; Figure 3c,e).
The splice variants distributed equally between principal and non-
principal neurons in the dentate gyrus.
These results suggest that GluK1b and GluK1c differ in their cell-
type specific expression patterns as well as in their developmental
regulation. At P3, the expression of GluK1 in pyramidal cells can be
fully explained by the expression of theGluK1c splice variant. During
development, the expression of GluK1c decreases significantly, and
as a consequence the expression of GluK1 in the pyramidal neurons
is lost.
Subcellular targeting of GluK1c in dispersed cultures of
hippocampal neurons is regulated by GluK4 and GluK5 subunits.
The in situ - data shows that GluK1c is the main splice variant
Figure 3 | GluK1b and GluK1c splice variants are preferentially expressed in principal neurons and interneurons of the neonate hippocampus,
respectively. (a) RT-PCR results illustrating expression of GluK1b and -c splice variants in the neonatal and juvenile hippocampus. GluK1a was not
detected in the hippocampus at either developmental stage. (b) Dark field in situ hybridization images showing the GluK1b and -c (S35)mRNA expression
in the neonate (P3) hippocampus. Scale 200mm. (c)Double in situ hybridization forGluK1b/c (S35) andCaMKII-b (dig) in areas CA1, CA3 and in dentate
gyrus (DG) at P3. GluK1b/c staining is mainly detected in CaMKII-b negative cells (white arrows) while GluK1c staining strongly colocalizes with
CaMKII-b in the principal neurons (Black arrows). Scale 50 mm. (d) Quantified data on the developmental regulation of the GluK1b/cmRNA expression
in the hippocampus. Values represent the percentage of the GluK1 mRNA expression at P15 as compared to the level at P3, analyzed from x-ray films
exposed to sections from parallel in situ hybridizations at the two developmental stages. Both splice variants are strongly downregulated during
development. (e) Quantified data on the distribution of GluK1b/c and c splice variants in pyramidal neurons vs. interneurons in different areas of
hippocampus. The values represent the percentage of pyramidal neurons (i.e. double positive cells) of all GluK1-expressing cells at P3. 66–127 neurons
from at least 4 sections were analyzed for each group. All the error bars depict s.e.m. *** p,0.005 with ANOVA on the raw data.
www.nature.com/scientificreports
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expressed in pyramidal neurons in the neonate hippocampus and
suggest that GluK1c, probably as heteromeric receptor with GluK4/
5, is responsible for the tonic presynaptic KAR activity early in
development. However, it is not known whether these receptors
can localize to axonal compartment in hippocampal neurons.
Since the lack of specific antibodies for GluK1 prevents analysis
of subcellular localization of the endogenous protein, we produced
epitope tagged constructs for GluK1c, GluK4 and GluK5 in
lentiviral vector under synapsin-1 promoter to drive neuron
specific expression. By lentiviral expression we were able to
screen a high number of neurons as the transduction efficiency
in dispersed hippocampal neurons was close to 100%.
The subcellular localization pattern of flag-tagged GluK1c was
divided into two groups; neurons in which GluK1 was detected only
in soma and proximal dendrites (restricted to soma-group) and neu-
rons in which GluK1 was also detected in distal dendritic processes
(distal dendrites-group). In addition, axonal localization was ana-
lyzed by identifying flag-stained neuronal processes lacking MAP2-
immunostaining. When expressed alone, GluK1c was mainly
restricted to soma and proximal dendrites (61% of neurons,
n5245) (Figure 4a,b), and GluK1c staining in axons was only
detected in a subset of neurons expressing GluK1 in distal dendrites
(5% of all neurons, 11% of neurons expressing GluK1c in distal
dendrites; n 5 245).
Localization of GluK1a splice variant within the dendritic com-
partment has been shown to depend on GluK2 and GluK524. To
study whether the high-affinity subunits were able to change the
subcellular targeting of GluK1c splice variant, it was co-expressed
with either GluK4 or GluK5 in hippocampal neurons. Co-expression
of both GluK4 and GluK5 clearly increased the proportion of cells
where GluK1c splice variant was detected in the distal dendrites
(171% and 176%, of the level with GluK1c alone, respectively;
n5336 and n5167; Figure 4a,c). The axonal localization of
GluK1c was apparently enhanced upon GluK4 co-expression
(152%), although this effect did not reach statistical significance. In
contrast, co-expression of GluK5 significantly reduced the fraction of
cells in which GluK1c was detected in axons (10%).
GluK1c localizes to dendritic contact sites at distal axons. Weak
expression in the axonal processes is difficult to observe in a
dispersed cell culture, thus complicating the analysis of GluK1
axonal localization. To overcome this problem, we cultured
hippocampal neurons in compartmentalized chambers25. These
microfluidic culture platforms contain small tunnels where axons,
due to their faster growth rate, grow in isolation25, thus allowing their
high-resolution imaging without dendritic of somatic conta-
mination. Since glial cells no not invade the tunnels in these
culture platforms, we were able to further enhance the resolution
of analysis by expressing the KAR subunits under strong but not
neuron specific CMV promoter. As shown before, dendritic
growth was only observed in the initial part of the tunnel, and no
MAP2 positive processes were detected . 300 mm from the tunnel
opening (Figure 5a; 25,26). Analysis GluK1c expressing neurons
indicated that this subunit was indeed localized in the distal axons
(59% of the axons in the middle section of the tunnels, n5136;
Figure 5 a,b,d). Rate of lentiviral transduction was estimated by
parallel pLen-Syn1/GFP infection, and was 70% (n568). Co-
expression of GluK4 did not change the percentage of GluK1c
positive axons (58%, n5143) in contrast to co-expression of
GluK5, which reduced axonal localization of GluK1c (38%, n575;
p50,013 as compared to GluK1c alone; Figure 5c,d). On the other
hand, the axonal localization of GluK4 but not GluK5 was slightly
Figure 4 | Heteromerization with GluK4 and GluK5 promotes distal targeting of GluK1c in cultured hippocampal neurons. (a) Confocal images from
cultured hippocampal neurons transduced with flag-GluK1c alone or together with myc-GluK4/5. Cells were stained with anti-flag (red) and anti-MAP2
(green) antibodies to visualize GluK1 and dendritic processes, respectively. GluK1c staining in MAP-negative (axonal) processes is indicated by arrows.
(b)Quantified data on subcellular localization of GluK1c splice variant. The neurons were divided in groups where GluK1was either restricted to soma or
also localized in distal dendrites. The axons-group represent neurons with flag(GluK1) – stained, MAP2-negative processes. The data represents the
percentage of cells in each group and analysis of 245 neurons from 3 independent stainings. (c) The effect of GluK4 and GluK5 co-expression on
subcellular localization of GluK1c. GluK4 co-expression enhanced localization of GluK1c in distal dendrites, while there was no significant effect on its
axonal targeting. GluK5 co-expression promoted dendritic localization of GluK1c with associated reduction in axonal staining. The data represents
analysis of 167–336 neurons from at least 3 independent stainings, and has been normalized to the data shown in b, (i.e. no change in localization as
compared to expression of GluK1c alone 5 100%). All the error bars depict s.e.m. *** p,0.005 with ANOVA on the raw data.
www.nature.com/scientificreports
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increased when GluK1c was co-expressed (Figure 5e). These data
confirm that GluK1c as well as the high-affinity subunits GluK4
and GluK5 are targeted to the distal axons and are appropriately
localized to regulate transmitter release.
Interestingly, high magnification images illustrated that while all
of the subunits were detected both in the axonal shaft as well as in
filopodial protrusions, GluK1c co-localized with GluK4 and GluK5
only in a subset of the immunostained axonal structures (Figure 5c).
While GluK4 and in particular, GluK5 were most prominently
detected at the axonal protrusions, GluK1c was preferentially loca-
lized to the axon shaft. The axons in the middle of the tunnels lack
dendritic contacts, and the protrusions likely represent immature
structures looking for postsynaptic target. At the end of the tunnels,
however, axons contact dendrites from the non-infected side of the
chamber. In this part, GluK1c was clearly localized at the dendritic
contact site together with GluK4, while there was less co-localization
of GluK1c with GluK5 (Figure 5f).
Presynaptic expression of GluK1c leads to robust inhibition of
synaptic transmission in CA3-CA3 neuron pairs. The expression
pattern and subcellular localization of GluK1 splice variants support
the hypothesis that presynaptic functions of kainate receptors
Figure 5 | High-resolution analysis of axonal GluK1c using microfluidic hippocampal cultures. (a) Confocal image showing an example of lentivirally
infected hippocampal neurons grown in a compartmentalized (microfluidic) culture. The culture platform has small tunnels extending from the main
reservoir (top), that allow entry of neurites but not cell bodies. MAP2 immunostaining (red) illustrates growth of dendritic processes only in the initial
part of the tunnel (, 300mmfrom tunnel opening) but not in themiddle (lower panels). anti-myc (green) and anti – flag (blue) immunostaining was used
to visualize lentivirally expressed GluK4-myc and GluK1c – flag in the axons. Scale 7 mm (for all panels in b,c,f).(b) A high-magnification figures from the
mid-part of the tunnels, illustrating expression of GluK1c –flag, GluK4-myc and GluK5-myc in axonal shaft and protrusions. (c) Co-expression of
GluK1c-flag with GluK4-myc (top) or GluK5-myc (lower panel). Co-localization (arrows) in isolated axons was observed mainly in the axon body and
only in a subset of axonal protrusions. (d) Quantified data on axonal localization of GluK1c. The values represent percentage of immunopositive axons
from all detected axons (n575–144/group), calculated from confocal and bright field images from the middle section of the tunnel, respectively. Axonal
localization of GluK1c was slightly reduced uponGluK5 but not GluK4 co-expression. * p,0.05 with ANOVAon the raw data. (e) Similar data as in d, for
axonal localization of GluK4 and GluK5 when expressed alone or together with GluK1c. Co-expression of GluK1c enhanced detection of GluK4 in axons.
(f) Confocal pictures from the end of the tunnels, illustrating localization of GluK1c-flag co-expressed with GluK4-myc (top) or GluK5-myc (lower
panel). The infected axons crawl on non-infected dendrites (red, MAP2 staining) that enter the tunnels from the other side of the chamber. Merged
images show axonal GluK1c staining in the dendritic contact site (arrows), where it co-localizes with GluK4 and, to lesser extent with GluK5.
www.nature.com/scientificreports
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during early development aremediated by GluK1c containing KARs.
To directly test whether presynaptic expression of GluK1c is able to
regulate synaptic transmission, CA3 pyramidal neurons in
organotypic hippocampal cultures were infected with double-
promoter lentiviral vectors containing GluK1c and EGFP under
separate synapsin – 1 promoters (GluK1c_EGFP). Control slices
were infected with a similar construct containing the GluK1b
splice variant. It should be noted that the CA3 pyramidal neurons
endogenously express GluK2, GluK4 and GluK5 KAR subunits to
promote surface expression and distal targeting of GluK1 (e.g. 18,
11, 24).
Whole cell recordings weremade from cell pairs, one of which was
EGFP positive (i.e. lentivirally transduced). Depolarization induced
action-potential firing in the transduced neuron induced post-
synaptic glutamatergic current (EPSCs) in 20–30% of the recorded
cell pairs (29% (n534) and 20% (n560) for control and GluK1c,
respectively). The percentage of synaptically connected neurons
in infected slices was slightly lower as compared to wild-type (non-
infected) slices (40% (n540)). Analysis of the EPSCs indicated that
expression of GluK1c in the presynaptic neuron significantly
reduced the success rate of EPSCs (Figure 6a,b,e). The mean ampli-
tude of the successful EPSCs (potency) was slightly but not signifi-
cantly reduced (Figure 6f). Further, paired pulse facilitation was
higher in cell pairs expressing GluK1c presynaptically as compared
to controls (Figure 6c,d,g). Together, these data indicate that presy-
naptic expression of GluK1c strongly reduces glutamate release
probability.
To test whether the altered presynaptic function in GluK1 expres-
sing neurons is due to ongoing tonic inhibition of glutamate release
by presynaptic KAR, we applied ACET (100 nM), a selective ant-
agonist of GluK1 subunit containing KARs27. In control neurons,
ACET had no significant effect on EPSCs although a small run-down
of the success rate was observed (Figure 6h). In neuron pairs where
GluK1c was expressed presynaptically, ACET application increased
the success rate to 138 6 13% of control with no associated changes
in potency (n54). ACET was not able to enhance transmission effi-
cacy to control levels, suggesting that GluK1c overexpression also
resulted in enduring changes in the synaptic machinery that were
independent on ongoing KAR activity.
Expression of GluK1c at juvenile CA3 mimics the immature-type
KAR activity at CA3-CA1 synapses. The data from organotypic
cultures indicate that expression of GluK1c at the presynaptic
neuron can significantly inhibit glutamatergic transmission and
thus mimic the tonic KAR activity that is observed at immature
CA3-CA1 synapses. To study whether expression of recombinant
GluK1c can recapitulate the immature type KAR activity at
developmental stage when it is no longer endogenously expressed
in the CA3, we used the lentiviral vectors (control (EGFP),
GluK1c_EGFP) to infect CA3 area of neonatal (P0-P2) rat pups.
Patch clamp recordings were made from CA1 pyramidal neurons
in acute slices at P14-P15. Only slices where a strong fluorescence
signal was detected selectively in area CA3were used for experiments
(Figure 7a).
The tonic KAR mediated inhibition at immature synapses is typ-
ically observed as smaller EPSC amplitude as well as an increase in
the facilitation of EPSCs in response to short high-frequency stimu-
lation5. Infection with the control virus had no significant effect on
the EPSCs evoked by 5 pulses at 50 Hz as compared to non-infected
animals (not shown). In contrast, expression of GluK1c caused sig-
nificant inhibition of the amplitude of the first EPSC to a fixed test
pulse as well as an increase in the facilitation of the following EPSCs
during the 5 pulse 50 Hz stimulation (Figure 7b–d). We ensured
pharmacologically that this effect was in fact due to GluK1 activity.
In GluK1c infected animals, EPSC amplitude was increased to 303 6
76% and the facilitation ratio decreased to 55 6 4% of the baseline
level in the presence of ACET (100 nM)(n55; Figure 7e). These data
strongly suggest that GluK1c splice variant inhibits glutamate release
and is responsible for the tonic inhibition of transmission at imma-
ture CA3-CA1 synapses.
Discussion
Ionotropic glutamate receptor subunits undergo extensive post-tran-
scriptional and post-translational modifications that may directly
reflect their physiological role, by controlling biophysical properties,
subcellular targeting and intracellular signaling of the receptors.
However, very little is known about regulation and physiological
functions of KAR splice variants. Here we show that developmentally
restricted expression of GluK1c in the pyramidal neurons of the
neonate hippocampus underlies tonic inhibition of glutamate release
at immature synapses.
The expression of all the KAR subunits is regulated to some extent
during development18,19. The mRNA of the GluK1c splice variant
showed a particularly pronounced developmental regulation, being
detected mainly (but not exclusively) in the pyramidal neurons and
dentate granule cells during early postnatal development, after which
a low level of expression was confined to the granule cells. During the
first postnatal weeks, the granule cell population is developmentally
heterogeneous28, with new progenitors being generated until adult-
hood. Thus, it is possible that similar to pyramidal neurons, the
expression of GluK1c in the granule cells is associated with a certain
phase of maturation; these cells could be detected at various ages due
to ongoing development of the region.
Intriguingly, the expression pattern of GluK1c corresponds well to
the existing pharmacological data on endogenous GluK1KARs regu-
lating glutamate release. The developmentally restricted expression
at the pyramidal neurons parallels the immature-type tonic KAR
activity at the CA3-CA1 and CA3-CA3 synapses5,9, while the express-
ion in the granule cells supports the role of presynaptic GluK1 in
the frequency-dependent regulation of transmission at the mossy
fibre synapse (e.g. 29). Finally, in addition to the effects on glutama-
tergic transmission, high-affinity GluK1 containing KARs have been
shown to tonically inhibit GABA release from immature mossy fibre
terminals30; an effect which could manifest the GluK1c expression in
the neonate granule cells. On the other hand, expression of the
GluK1b in the non-principal neurons throughout the early postnatal
development suggests that this splice variant is mainly responsible for
the functions attributed to GluK1 containing KARs in the GABAergic
interneurons in the neonate hippocampus31,32.
Since the immature-type KARs regulating glutamate release have
a high agonist affinity, they likely contain either the subunit GluK4
or GluK5 in addition to GluK1c5. Furthermore, it has been suggested
that heteromeric KARs possess binding and desensitization charac-
teristics that can be localized to the particular subunit subtypes33,15.
In particular, expression of GluK4/5 subunits confer a high-affinity,
non-desensitizing agonist binding site15 that may well underlie
tonic KAR activity in the immature neurons. Data from GluK4 2/2
and GluK4 2/2/GluK52/2 animals suggest that these subunits are
also critical for localizing KARs at both pre and postsynaptic sites34.
While GluK5 has been reported to target GluK1a to distal dendrites24,
no previous data exists regarding the subcellular targeting of
heteromeric GluK1c -GluK4/5 receptors. Our data confirms that
GluK1c is localized in both distal dendrites as well as in axons of
hippocampal neurons. Interestingly, co-expression of either of the
high-affinity subunits GluK4 and GluK5 hippocampal neurons pro-
moted localization of GluK1c at distal dendrites. In contrast to
GluK4, however, GluK5 co-expression appeared to specifically pro-
mote polarized targeting of GluK1c to dendritic compartment, with
associated reduction of GluK1c in axons. High-resolution images of
recombinant GluK1c in isolated axons show that this subunit is
localized to both, the axon body and axonal protrusions, where it
partially co-localizes with the co-expressed high-affinity subunits
www.nature.com/scientificreports
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GluK4/5. Upon formation of dendritic contact, axonal GluK1c was
clearly detected at the dendritic contact sites, where it prominently
co-localized with GluK4 and also (but apparently to lesser extent)
with GluK5. These data fully support the idea that heteromeric KARs
containing GluK1c and GluK4/5 subunits are presynaptically loca-
lized at immature synapses.
KARs have been implicated in physiological regulation of trans-
mitter release in a variety of synapses, either via an ionotropic
action facilitating presynaptic calcium dynamics and conse-
quently, transmitter release, or via a G-protein dependent meta-
botropic mechanism that typically inhibits release (reviewed in 3).
However, the molecular identity of presynaptic KARs and in
Figure 6 | Presynaptic expression of GluK1c inhibits glutamate release. (a,b) Example traces of whole cell recordings in CA3 pyramidal neuron pairs in
organotypic slices. Five superimposed traces illustrate postsynaptic responses, recorded under voltage clamp under control conditions, and evoked by
action-potential-inducing depolarization of the presynaptic neuron (bottom trace), that has been infected with a control virus (GluK1b_EGFP) (a) or
GluK1c_EGFP (b). (c,d) Average of 20 consecutive traces, recorded in response to stimulation of control (c) and GluK1c (d) infected neurons. (e) Pooled
data on the success rate of EPSCs in response to first and second depolarizing presynaptic pulse at control neuron pairs (non-infected, n516; infectedwith
control virus, n513), as well as in pairs where GluK1c_EGFP is expressed presynaptically (n512). (f) Analysis of the EPSC potency and paired pulse ratio
(g) from the same data. (h) Normalized data on the effect of ACET (100 nM) on the success rate and potency of EPSCs, at control neuron pairs (non-
infected n55; infected n54), as well as in pairs where GluK1c_EGFP is expressed presynaptically (n54). All the error bars depict s.e.m. * p,0.05 with
ANOVA.
www.nature.com/scientificreports
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particular, the role of GluK1 subunit has been under debate,
since pharmacological and genetic studies have given apparently
contrasting results (e.g. 28,35). Our recordings of cell pairs expres-
sing GluK1c presynaptically provide compelling functional evid-
ence for its involvement in the regulation of glutamate release.
With this experimental approach, the spatially restricted express-
ion of the gene construct as well as the cell-specific stimulation
reduces the potential compensatory or indirect effects due to
altered network behavior. Overexpression of the GluK1c in the
presynaptic neuron lead to a robust reduction in the success
rate of EPSCs, accompanied with an increase in paired pulse
facilitation; both indicators of reduced probability of glutamate
release. Interestingly, these effects were only partially reversed
by application of the GluK1 selective antagonist ACET, suggesting
that presynaptic GluK1c expression may cause also lasting
changes in the functional connectivity6.
The clear effect of the presynaptic GluK1c on transmission in vitro
encouraged us to test whether the developmental KAR function can
be recapitulated by expressing GluK1c in CA3 pyramidal neurons at
two-three week old animals, where its endogenous expression is
already downregulated. CA3 pyramidal neurons at juvenile and adult
hippocampus express high levels of GluK4 mRNA18,23, putatively
Figure 7 | The immature type KAR activity at CA3-CA1 synapses is mimicked by lentiviral expression of GluK1c in area CA3 at P14–P15.
(a) Fluorescence signal in the CA3 pyramidal area at P14, following local stereotaxic infection with EGFP- containing lentivirus at P1. Scale bar: 50 mm.
(b) Example traces of EPSCs, recorded fromCA1 pyramidal neurons in response to 5 pulse 50 Hz afferent stimulation in slices (P15) expressing EGFP (5
control) or GluK1c_EGFP in area CA3. (c) Pooled data on the amplitude of the first EPSC in the train in slices (P14–P15) infected with a control virus
(n514) or GluK1c_EGFP (n517) in area CA3. (d) Analysis of the facilitation ratio (amplitude of 5th/1st EPSC in the 50 Hz train) from the same data as in
c. (e) The effect of ACET (100 nM) on EPSCs, evoked by 5 pulse 50 Hz stimulation in slices expressing GluK1c_EGFP in area CA3. Example traces of the
synaptic response in control conditions and in the presence of ACET. Scaled and superimposed traces illustrate reduced facilitation in ACET. Pooled data
(n55) on the effect of ACET on the amplitude of the 1st EPSC and on facilitation ratio.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 310 | DOI: 10.1038/srep00310 9
involved in axonal targeting and immature-type GluK1 function.
Indeed, upon expression of GluK1c but not EGFP, an ACET-sens-
itive synaptic facilitation was detected in the CA3-CA1 synapses,
similar to that seen during early postnatal development5. Thus, the
expression of GluK1c is sufficient tomimic the immature – typeKAR
activity in a physiological tissue environment.
In conclusion, both the mRNA expression profile and the ob-
served presynaptic effects of the GluK1c splice variant support its
central role in mediating tonic inhibition of glutamate release in the
immature hippocampal circuitry. This mechanism is involved in regu-
lation of the endogenous network activity9 as well as development of
glutamatergic synaptic connectivity in the neonate hippocampus5,6,
directly defining the physiological significance of the developmentally
restricted expression of the GluK1c and calling for detailed under-
standing of the signaling mechanisms specific for this splice variant.
Methods
Double in situ hybridization. Brains were taken from Wistar rats at postnatal days
(P)3 and P15. The tissue was fixed in 4% paraformaldehyde (PFA), parafinated, and
cut at 7 mm sections. The protocol for in situ hybridization was carried out essentially
as described in ref.36. Oligodeoxyribonucleotide probes complementary to rat brain
cDNAs are listed in the Supplementary Figure 1A. The fragments were cloned into a
pGEM-T vector (Promega, Madison, WI). Clones were linearized by restriction
digest and used as templates to generate sense and antisense S35-labeled or
Digoxigenin(dig) -labeled riboprobes. All probes were tested to ensure specific
staining with anti-sense probe and that there was no nonspecific signal with the sense
mRNA (Supplementary Figure 1b). In addition, the cross – reactivity between the
probes designed to differentiate GluK1 b and –c splice variants was controlled using
dot – blot assay (Supplementary Figure 1c).
Digital images were taken from stained sections using brightfield and darkfield
optics to visualize dig and radioactive labeling, respectively. The colors in the dark
field image were inverted and the image was superimposed with the corresponding
brightfield figure. Brightness and contrast were adjusted digitally using Adobe
Photoshop software to optimize signal to noise ratio. Calculations were made from
the photomicrographs from at least four rectangular regions (150 mm3750 mm)
positioned perpendicularly across the principal cell layer in areas CA1, CA3 and in the
dentate gyrus. From each region, all cells positive for the radioactive stain (GluK1,
GluK1b or GluK1c) were counted after which it was determined how many of these
were double positive, i.e. labeled with dig (CaMKII-b, GluK4 or GluK5). The quan-
tified data depicts the percentage of double positive cells of the cells detected by
radioactive labeling. The percentage values were obtained by analyzing approxi-
mately 50 cells for each group (n values between 36–120; the low n values correspond
to groups where the KAR expression level was very low).
RT-PCR.RNAwas extracted fromhippocampi of P3/P15 rats using RNeasyMini Kit
(Qiagen). cDNAwas synthetized from 1 mg of total RNAwith oligo-dT primers using
RETROscriptH (Ambion) reverse transcription (RT) kit. PCR on the RT products
was performed in two rounds using common forward primers and GluK1 splice
variant-specific reverse primers as indicated in the Table 1. The amplification
products were separated on 2% agarose gel and stained with EtBr.
Generation of expression plasmids and lentiviral particles. Plasmids encoding
epitope – tagged kainate-receptor subunits were constructed using a modified
expression vector which contains a backbone of pEGFP-C1 (Clontech) and EGFP/
Flag/6*Myc-epitope linked by multiple cloning sites (MCS) at both ends (dMCS).
The cDNA of the various KAR subunits were generated by PCR from rat brain cDNA
library, or fromGluR5-2a/pRK7 (gift fromA. Nishimune and J. Henley, University of
Bristol, UK), and subcloned into the dMCS-vector in two steps; first the predicted
signal sequence was inserted before the epitope into MCS I and then the rest of the
sequence was cloned into MCS II. KA2-myc/pcDNA3 was kindly provided by F.
Coussen and C. Mulle (University of Bordeaux, France). The epitope tagged
constructs were subcloned into lentiviral transfer vector under synapsin or CMV
promoter (pLen-Syn1/CMV; modified from pWPT-GFP, that was kindly provided
by Didier Trono (Lausanne, Switzerland)). For electrophysiology experiments,
6*myc-tagged-GluK1b/c was cloned into pLen-vector containing two separate
synapsin1 promoters, first driving the expression of GluK1 and the second the
expression of EGFP. All constructs were verified by restriction mapping and by
sequencing of PCR-amplified regions. The appropriate size of the encoded
recombinant proteins was confirmed by western blot of transfected HEK293t cells.
For production of lentiviral particles, HEK293t cells were seeded at the density of
33106 on 10 cm2 plates and transfected with Fugene6 (Roche Applied Science) on the
following day using 0.75 mg envelope-coding plasmid pMD.G, 2.25 mg packaging
plasmid psPAX2 and 3 mg of transfer vector (derivate of the original pHR’ backbone).
Medium containing the viral particles was harvested 48 hours post-transfection,
cleared of debris by low-speed-centrifigation and concentrated immediately by ultra-
centrifugation (50 000 g, 2 hours at 14uC) or with PEG-itTM virus precipitation
solution (System Biosciences). Pellets were suspended inDMEM or PBS in 1/100-1/200
of the original volume. The titers of the lentiviral stocks were determined with ELISA
assay (Aalto Bioreagents) and were typically 13107213108 transducing units/ml.
Neuronal cultures and lentiviral infections. Hippocampi were dissected from 17/
18-d-old rat embryos, treated with papain (500 mg/ml) andmechanically triturated to
produce a single-cell suspension. Cells were seeded at the density of 40,000 cells/cm2
on poly-L-ornithine (5 mg/ml, Sigma-Aldrich) 1 laminin (1.5 mg/cm2, Sigma-
Aldrich) -coated coverslips in Neurobasal mediumwith 2%B27 supplement, 0.5 mM
L-glutamine, and 1x penicillin-streptomycin (all from Invitrogen). For
compartmentalized cultures, the neurons were plated on microfluidic culture
chambers that were mounted on poly-L-lysine (0.01%, Sigma) coated coverslips
(24 mm324 mm)25,26. Neuron cultures were infected with lentiviruses at 7–8 DIV
(dispersed cultures) or 3 DIV (microfluidic cultures) by adding 1–3 ml of
concentrated lentiviruses for 40,000 cells, so, that the transduction efficiency reached
70–100 %. Transduced neurons were analyzed at DIV 13–15.
Immunostaining of cultured neurons. For immunostainings, cells were washed
with phosphate-buffered saline (PBS, pH 7.4) and fixed with 4% PFA in PBS for 15–
20 minutes at room-temperature (RT). In experiments with compartmentalized
cultures, coverslips containing fixed cells were detached from the microfluidic
chamber. Fixed cells were either permeabilized with 0.25% Triton-X and blocked
with 5% milk powder in PBS, or treated directly with blocking buffer containing 5%
goat serum, 1% BSA, 0.1% gelatin, 0.1% Triton X-100, 0.05% Tween-20 in PBS.
Primary antibodies (mouse anti-flag, 151500, Sigma-Aldrich; chicken anti-MAP2,
158000, Synaptic Systems and rabbit anti-Myc, 151500, Millipore) were added in
blocking solution and cells were incubated over-night with shaking at 14uC. Cells
were then washed several times with PBS before incubation with secondary
antibodies (AlexaFluor 568 goat anti-mouse, AlexaFluor 488 goat anti-chicken,
AlexaFluor 568 goat anti-chicken; AlexaFluor 488 goat anti-rabbit; AlexaFluor 405
goat anti-mouse; 15500 dilution, Molecular Probes) for 1.5–2 hours RT. After
washing the coverslips were mounted using FluorSaveTM (Calbiochem) or
ProlongGold Antifade (Iinvitrogen) reagent.
Immunostained samples of dispersed cultures were analysed with confocal micro-
scope (Zeiss LSM 5 Pascal with Axioplan 2 microscope, using a C-Apochromat 403,
N.A 1.2 water objective). Images were taken at 1 mm interval, stacked and analyzed
using Zeiss LSM Image Browser and Adobe photoshop software. Neurons from each
image were grouped according to GluK1 localization: neurons in which GluK1 was
localized strictly to soma (5 restricted to soma-group) and neurons in which GluK1
was also detected in distal dendrites (.50 mm from the soma; distal dendrites-group).
Axonal localization was defined as GluK1 positive but MAP2 (dendritic marker)
negative processes. At least 150 neurons for each construct were analyzed. The
quantified data depicts the percentage of cells in each group of all counted cells.
The images of microfluidic cultures were taken with MP Leica TCS SP5 confocal
microscope, using HPX PL APO 63x 1.30 objective. Axonal processes, negative for
MAP2 staining, 350–550 mm from the tunnel opening were used for quantification.
Fluorescent images were taken at 0.5 to 0.75 mm interval, stacked and analyzed with
Adobe Photoshop software. Bright field images were taken in parallel to determine
total number of axons. On an average, 115 axons per condition were analyzed. The
quantified data represents percentage of axons expressing KAR subunits with respect
to total number of axons in mid part of tunnel in the same image frame. All the
statistics have been calculated from the raw data.
Table 1 | Primers used for RT-PCR
First PCR GluK1 forward1 TAAAAACAGTGACGAGGGGATCCA
GluK1a reverse1 AGGGTTATCAAGGCATACGACAC
GluK1bc reverse1 GGTGACAAGTAAGGATACTTGTG
Second PCR Common forward primer2 CGATTGCCATTCTTCAACTGCAAG
GluK1a reverse2 CAAGGCATACGACACTTCAGTA
GluK1b reverse2 CATTGAAAGAGAGACACTGCTC
GluK1c reverse2 GAAAGAGAGACACTTCTCTACACC
Control GAPDH forward CAACGACCCCTTCATTGACC
GAPDH reverse AGTGATGGCATGGACTGTGG
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Dual recordings in hippocampal slice cultures.Organotypic cultures were prepared
from postnatal day 7–8 (P7-8) Wistar rats as described previously6. Targeted
lentiviral infections were done on the day after plating (DIV1), by injecting 1–2 ml of
the lentiviral suspension to the CA3 area using a micromanipulator and Narishige
IM-31 microinjector. For electrophysiological recordings, the cultures (9–11 DIV)
were placed in a submerged recording chamber (RT) mounted on Olympus BX51
fluorescence microscope, and constantly superfused with an extracellular solution
containing (mM): 124 NaCl, 3 KCl, 1.25 NaH2PO4, 1 MgSO4, 26 NaHCO3, 15 D-
glucose, 2 CaCl2 and 20 sucrose (320 mOsm; bubbled with 5% CO2–95% O2). Patch
electrodes (3–5 MV) contained the following (mM): 140 K-gluconate, 10 Hepes, 2
KCl, 0.1 EGTA, 4 Mg-ATP, 0.5 Na-GTP and 20 sucrose (300 mOsm, pH 7.2).
Infected neurons were identified based on EGFP fluorescence. Simultaneous whole-
cell recordings were obtained from a fluorescent and non-fluorescent pyramidal
neuron in CA3 area using Multiclamp 700A amplifier (Molecular Devices, USA).
Brief depolarizing steps (10 ms, 500–800 pA) at 10 s intervals were given under
current clamp to evoke action potentials in the fluorescent neuron while recording
the activity of the non-fluorescent neuron under voltage-clamp (270 mV). An
inward current with amplitude at least three times the average noise level and with
invariable delay less than 10 ms was considered as successful EPSC in the
postsynaptic cell. Cell pairs with no detectable responses to 50 trials were rejected
from the analysis. For calculation of the success rate and paired pulse facilitation ratio
(with 50 ms inter-pulse interval), 50 successive sweeps were collected, after which
ACET (100 nM) was applied extracellularly. Potency was calculated as the average
amplitude of successful EPSCs.
In vivo infections and electrophysiology. Lentiviral particles were injected to the area
CA3 of 0–2 day old rat pups under isoflurane anaesthesia. The animals were placed
onto stereotaxic frame, the skull was exposed and a small hole was done using dental
drill. 0.5 ml of lentiviral suspension was injected into CA3 region of hippocampus. The
stereotaxic coordinates for CA3 were recalculated in the respect to bregma – lambda
distance and varied in the following range: AP 1.8–2.2, ML 2.8–3.2, DV 2.8–3.0. The
wound was treated with bacibact (Orion Pharma, Finland), sutured and the pup was
left to recover with the dam. At P14–P15, acute hippocampal slices were made using
standard methods (e.g. 5). Slices with clear fluorescence in area CA3 but not in CA1
were placed in a submerged recording chamber and perfused with extracellular
solution containing (mM): NaCl, 124; KCl, 3; NaH2PO4, 1.25; MgSO4, 1; NaHCO3, 26;
D-glucose, 10–15; CaCl2, 2 ; 5% CO2 / 95% O2, RT. Whole cell voltage clamp
recordings were made fromCA1 pyramidal cells, with patch electrodes (2–5 MV) filled
with a solution containing (in mM) CsMeSO4, 130; HEPES, 10; EGTA, 0.5; Mg-ATP, 4;
Na-GTP, 0.3; QX-314, 5; NaCl, 8; 285 mOsm, pH 7.2. AMPA-R mediated EPSCs were
evoked by stimulation of Schaffer collateral-commissural fibres with a bipolar electrode,
and recorded in the presence of antagonists of GABAA and NMDA receptors
(picrotoxin (PiTX) [100 mM] and L689250 [5 mM], respectively). Baseline stimulation
frequency was 1/20 sec. For train stimulation, 5 pulses were given at 50 Hz at 30 s
intervals, and at least 10 trials were averaged for analysis. pClamp software was used for
all data collection and analysis.
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